Clinical Experience With Prolonged-Release Nicotinic Acid in Statin-Treated Patients Managed in the Usual-Care Setting in Austria: An Analysis from Niaspan®-Induced HDL-Elevation for Optimizing Risk Control (NEMO) Study

Drexel H; Rein P; Hostalek U; Kastelein J

Drexel H et al.

Clinical Experience With Prolonged-Release Nicotinic Acid in Statin-Treated Patients Managed in the Usual-Care Setting in Austria: An Analysis from Niaspan®-Induced HDL-Elevation for Optimizing Risk Control (NEMO) Study

Journal of Clinical and Basic Cardiology 2007; 10 (1-4): 7-10

PDF Summary Figures

Figure

Maximize View	NEMO study Figure 1: Incidences of flushing during the NEMO study. Percentages refer to overall populations (n = 220 for the Austrian population and n = 1053 for the overall population). The severity of flushes was rated by study investigators. Keywords: Austria, Diagramm, flowchart, NEMO study, NEMO-Studie, Österreich


Maximize View	Lipid profiles Figure 2: Effects on lipid profiles (means ± SE). Keywords: Diagramm, flowchart, LIPID, lipid profile, NEMO study, NEMO-Studie